List of Myriad Genetics patents

Patents where

Current Assignee

Name

Myriad Genetics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7410944 Depression gene	Patent 7410944 was granted and assigned to Myriad Genetics on August, 2008 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7410944	August 12, 2008
‌ US Patent 7572905 Depression gene	Patent 7572905 was granted and assigned to Myriad Genetics on August, 2009 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7572905	August 11, 2009
‌ US Patent 7374884 Diabetes gene	Patent 7374884 was granted and assigned to Myriad Genetics on May, 2008 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7374884	May 20, 2008
‌ US Patent 7195873 Drug response marker in beta-1 adrenergic receptor gene	Patent 7195873 was granted and assigned to Myriad Genetics on March, 2007 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7195873	March 27, 2007
‌ US Patent 7141401 COX1-interacting proteins and use thereof	Patent 7141401 was granted and assigned to Myriad Genetics on November, 2006 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7141401	November 28, 2006
‌ US Patent 11505832 Method of using biomarkers and clinical variables for predicting chemotherapy benefit	Patent 11505832 was granted and assigned to Myriad Genetics on November, 2022 by the United States Patent and Trademark Office.	Myriad Genetics	Myriad Genetics	United States Patent and Trademark Office	11505832	November 22, 2022
‌ US Patent 7297515 Zinc finger proteins	Patent 7297515 was granted and assigned to Myriad Genetics on November, 2007 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7297515	November 20, 2007
‌ US Patent 7511039 β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins	Patent 7511039 was granted and assigned to Myriad Genetics on March, 2009 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7511039	March 31, 2009
‌ US Patent 7563571 MYH gene variants and use thereof	Patent 7563571 was granted and assigned to Myriad Genetics on July, 2009 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7563571	July 21, 2009
‌ US Patent 7202329 Tsg101-GAGp6 interaction and use thereof	Patent 7202329 was granted and assigned to Myriad Genetics on April, 2007 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7202329	April 10, 2007
‌ US Patent 9605319 Gene signatures for cancer diagnosis and prognosis	Patent 9605319 was granted and assigned to Myriad Genetics on March, 2017 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	9605319	March 28, 2017
‌ US Patent 7250497 Large deletions in human BRCA1 gene and use thereof	Patent 7250497 was granted and assigned to Myriad Genetics on July, 2007 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7250497	July 31, 2007
‌ US Patent 7422853 RNA interference using a universal target	Patent 7422853 was granted and assigned to Myriad Genetics on September, 2008 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7422853	September 9, 2008
‌ US Patent 7335468 TSG101-GAG interaction and use thereof	Patent 7335468 was granted and assigned to Myriad Genetics on February, 2008 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7335468	February 26, 2008
‌ US Patent 11174517 Gene signatures for cancer prognosis	Patent 11174517 was granted and assigned to Myriad Genetics on November, 2021 by the United States Patent and Trademark Office.	Myriad Genetics	Myriad Genetics	United States Patent and Trademark Office	11174517	November 16, 2021
‌ US Patent D764581 Form	Patent D764581 was granted and assigned to Myriad Genetics on August, 2016 by the United States Patent and Trademark Office.	Myriad Genetics	Myriad Genetics	United States Patent and Trademark Office	D764581	August 23, 2016
‌ US Patent D764580 Form	Patent D764580 was granted and assigned to Myriad Genetics on August, 2016 by the United States Patent and Trademark Office.	Myriad Genetics	Myriad Genetics	United States Patent and Trademark Office	D764580	August 23, 2016
‌ US Patent 9976188 Cancer biomarkers	Patent 9976188 was granted and assigned to Myriad Genetics on May, 2018 by the United States Patent and Trademark Office.	Myriad Genetics	Myriad Genetics	United States Patent and Trademark Office	9976188	May 22, 2018
‌ US Patent 10954568 Gene signatures for cancer prognosis	Patent 10954568 was granted and assigned to Myriad Genetics on March, 2021 by the United States Patent and Trademark Office.	Myriad Genetics	Myriad Genetics	United States Patent and Trademark Office	10954568	March 23, 2021
‌ US Patent D764579 Form	Patent D764579 was granted and assigned to Myriad Genetics on August, 2016 by the United States Patent and Trademark Office.	Myriad Genetics	Myriad Genetics	United States Patent and Trademark Office	D764579	August 23, 2016
‌ US Patent 7547804 Compounds, compositions, and methods employing same	Patent 7547804 was granted and assigned to Myriad Genetics on June, 2009 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7547804	June 16, 2009
‌ US Patent 7405212 Helix mimetics and composition and methods related thereto	Patent 7405212 was granted and assigned to Myriad Genetics on July, 2008 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7405212	July 29, 2008
‌ US Patent 7662566 Gene copy number profiling	Patent 7662566 was granted and assigned to Myriad Genetics on February, 2010 by the United States Patent and Trademark Office.		Myriad Genetics	United States Patent and Trademark Office	7662566	February 16, 2010
‌ US Patent 9388472 Methods and materials for assessing loss of heterozygosity	Patent 9388472 was granted and assigned to Myriad Genetics on July, 2016 by the United States Patent and Trademark Office.	Myriad Genetics	Myriad Genetics	United States Patent and Trademark Office	9388472	July 12, 2016
‌ US Patent 11174519 Method of treating cancer	Patent 11174519 was granted and assigned to Myriad Genetics on November, 2021 by the United States Patent and Trademark Office.	Myriad Genetics	Myriad Genetics	United States Patent and Trademark Office	11174519	November 16, 2021

Results per page:

65 results

0 selected

65 results

0 selected